Notably, DW and IW treatments in PIL mice model not only reduced NETosis and ROS generation but also ameliorated lupus severity, as evidenced by diminished staining for NET-associated proteins (NE, CitH3) expressions in the kidneys, liver, and heart. This evidence concerns the gene ELANE and systemic lupus erythematosus.